Yıl: 2020 Cilt: 52 Sayı: 2 Sayfa Aralığı: 171 - 175 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2020.18443 İndeks Tarihi: 03-12-2020

Is Ebselen A Therapeutic Target in Fracture Healing?

Öz:
Objective: We investigated the effect of ebselen on fracture healing in an experimental fracture model.Materials and Methods: We divided rats into two groups, 6 rats in each: the experimental femur fracture control group and the ebselen treatment group with an experimental femur fracture. In the experimental femur fracture control group, we created only experimental femur fracture. In the ebselen treatment group, we administered ebselen treatment with creating an experimental femur fracture. We administered ebselen intraperitoneally at 5 mg/kg once daily for 1 month after the 1st day of experimental femur fracture in the ebselen treatment group. We evaluated the recovery status of fractured femurs at the end of 1st month with radiographic, histopathological, and immunohistochemical methods.Results: According to the radiographic fracture healing scores, ebselen treatment increased the extent of new bone formation and fracture cartilage callus significantly compared to the control group. According to the histopathological recovery scores, ebselen treatment significantly improved healing scores compared to the control group. Ebselen treatment increased the expression scores of bone healing markers in the ebselen treatment group, such as vascular endothelial growth factor and osteocalcin, compared to the control group.Conclusion: We demonstrated that ebselen treatment increases the formation of new bone in the femur in an experimentally created femoral fracture model. Ebselen has been shown to improve the bone fracture healing in a radiological and histopathological manner, and more detailed studies are needed.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Aydin A, Halici Z, Akpinar E,et al. What is the role of bosentan in healing of femur fractures in a rat model? J Bone Miner Metab 2015; 33: 496-506. [Crossref]
  • 2. Giannoudis PV, Kontakis G, Christoforakis Z, et al. Management, complications and clinical results of femoral head fractures. Injury 2009; 40: 1245-51. [Crossref]
  • 3. Papakostidis C, Bhandari M, Giannoudis PV. Distraction osteogenesis in the treatment of long bone defects of the lower limbs: effectiveness, complications and clinical results; a systematic review and meta-analysis. Bone Joint J 2013; 95-B: 1673-80. [Crossref]
  • 4. Giannoudis PV, Jones E, Einhorn TA. Fracture healing and bone repair. Injury 2011; 42: 549-50. [Crossref]
  • 5. Xu H, Watkins BA, Seifert MF. Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif Tissue Int 1995; 57: 293-300. [Crossref]
  • 6. Sarisozen B, Durak K, Dincer G, et al. The effects of vitamins E and C on fracture healing in rats. J Int Med Res 2002; 30: 309-13. [Crossref]
  • 7. Estai MA, Suhaimi FH, Das S, et al. Piper sarmentosum enhances fracture healing in ovariectomized osteoporotic rats: a radiological study. Clinics [Sao Paulo] 2011; 66: 865-72. [Crossref]
  • 8. Sakurai T, Kanayama M, Shibata T, et al. Ebselen, a seleno-organic antioxidant, as an electrophile. Chem Res Toxicol 2006; 19: 1196-204. [Crossref]
  • 9. Ullrich V, Weber P, Meisch F, et al. Ebselen-binding equilibria between plasma and target proteins. Biochem Pharmacol 1996; 52: 15-9. [Crossref]
  • 10. Zhao R, Masayasu H, Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc Natl Acad Sci 2002;99: 8579-84. [Crossref]
  • 11. Antony S, Bayse CA. Modeling the mechanism of the glutathione peroxidase mimic ebselen. Inorg Chem. 2011; 50: 12075-84. [Crossref]
  • 12. Miorelli ST, Rosa RM, Moura DJ, et al. Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells. Mutagenesis 2008; 23: 93-9. [Crossref]
  • 13. Nakamura Y, Feng Q, Kumagai T, et al. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis. J Biol Chem 2002; 277: 2687-94. [Crossref]
  • 14. Imai H, Masayasu H, Dewar D, et al. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke. 2001; 32: 2149-54. [Crossref]
  • 15. Noguchi N, Yoshida Y, Kaneda H, et al. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol 1992; 44: 39- 44. [Crossref]
  • 16. Schewe T. Molecular actions of ebselen--an antiinflammatory antioxidant. Gen Pharmacol 1995; 26: 1153-69. [Crossref]
  • 17. Chew P, Yuen DY, Stefanovic N, et al. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 2010; 59: 3198-207. [Crossref]
  • 18. Lindenblatt N, Schareck W, Belusa L, et al. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression. Thromb Haemost 2003; 90: 882-92. [Crossref]
  • 19. Nogueira CW, Rotta LN, Zeni G, et al. Exposure to ebselen changes glutamate uptake and release by rat brain synaptosomes. Neurochem Res 2002; 27: 283-8. [Crossref]
  • 20. Kasraee B, Nikolic DS, Salomon D, et al. Ebselen is a new skin depigmenting agent that inhibits melanin biosynthesis and melanosomal transfer. Exp Dermatol 2012; 21: 19-24. [Crossref]
  • 21. Morin D, Zini R, Ligeret H, et al. Dual effect of ebselen on mitochondrial permeability transition. Biochem Pharmacol 2003; 65: 1643-51. [Crossref]
  • 22. Chen J, Li H, Addabbo F, et al. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol 2009; 174: 701-11. [Crossref]
  • 23. Baek JM, Kim JY, Yoon KH, et al. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo. Int J Biol Sci 2016; 12: 478-88. [Crossref]
  • 24. Bubolz AH, Wu Q, Larsen BT, et al. Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol 2007; 293: H2231-7. [Crossref]
  • 25. Shuid AN, Mohamad S, Muhammad N, et al. Effects of alpha-tocopherol on the early phase of osteoporotic fracture healing. J Orthop Res 2011; 29: 1732-8. [Crossref]
  • 26. Kim SH, Kim JH, You DG, et al. Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis. Chem Commun [Camb] 2013; 49: 10349-51. [Crossref]
  • 27. Huo MH, Troiano NW, Pelker RR, et al. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res 1991; 9: 383-90. [Crossref]
  • 28. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-8. [Crossref]
  • 29. Huh JE, Kwon NH, Baek YH, et al. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol 2009; 9: 1357-65. [Crossref]
  • 30. Park CG, Joo MW, Jeong J, et al. Evaluation of the effects of the combination of autologous mesenchymal stem cells and platelet-rich plasma on structural bone allograft healing. Cell Tissue Bank 2017. [Crossref]
  • 31. Ingram RT, Clarke BL, Fisher LW, et al. Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 1993; 8: 1019-29. [Crossref]
  • 32. Hauschka PV, Lian JB, Cole DE, et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047. [Crossref]
  • 33. Goldstone AP, Howard JK, Lord GM, et al. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun 2002; 295: 475-81. [Crossref]
  • 34. Ngueguim FT, Khan MP, Donfack JH, et al. Ethanol extract of Peperomia pellucida [Piperaceae] promotes fracture healing by an anabolic effect on osteoblasts. J Ethnopharmacol 2013; 148: 62-8. [Crossref]
APA KÖSE A, KOSE D, Halici Z, Aydın A, Ezirmik N, KARSAN O, TOKTAY E (2020). Is Ebselen A Therapeutic Target in Fracture Healing?. , 171 - 175. 10.5152/eurasianjmed.2020.18443
Chicago KÖSE AHMET,KOSE DUYGU,Halici Zekai,Aydın Ali,Ezirmik Naci,KARSAN ORHAN,TOKTAY Erdem Is Ebselen A Therapeutic Target in Fracture Healing?. (2020): 171 - 175. 10.5152/eurasianjmed.2020.18443
MLA KÖSE AHMET,KOSE DUYGU,Halici Zekai,Aydın Ali,Ezirmik Naci,KARSAN ORHAN,TOKTAY Erdem Is Ebselen A Therapeutic Target in Fracture Healing?. , 2020, ss.171 - 175. 10.5152/eurasianjmed.2020.18443
AMA KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E Is Ebselen A Therapeutic Target in Fracture Healing?. . 2020; 171 - 175. 10.5152/eurasianjmed.2020.18443
Vancouver KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E Is Ebselen A Therapeutic Target in Fracture Healing?. . 2020; 171 - 175. 10.5152/eurasianjmed.2020.18443
IEEE KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E "Is Ebselen A Therapeutic Target in Fracture Healing?." , ss.171 - 175, 2020. 10.5152/eurasianjmed.2020.18443
ISNAD KÖSE, AHMET vd. "Is Ebselen A Therapeutic Target in Fracture Healing?". (2020), 171-175. https://doi.org/10.5152/eurasianjmed.2020.18443
APA KÖSE A, KOSE D, Halici Z, Aydın A, Ezirmik N, KARSAN O, TOKTAY E (2020). Is Ebselen A Therapeutic Target in Fracture Healing?. Eurasian Journal of Medicine, 52(2), 171 - 175. 10.5152/eurasianjmed.2020.18443
Chicago KÖSE AHMET,KOSE DUYGU,Halici Zekai,Aydın Ali,Ezirmik Naci,KARSAN ORHAN,TOKTAY Erdem Is Ebselen A Therapeutic Target in Fracture Healing?. Eurasian Journal of Medicine 52, no.2 (2020): 171 - 175. 10.5152/eurasianjmed.2020.18443
MLA KÖSE AHMET,KOSE DUYGU,Halici Zekai,Aydın Ali,Ezirmik Naci,KARSAN ORHAN,TOKTAY Erdem Is Ebselen A Therapeutic Target in Fracture Healing?. Eurasian Journal of Medicine, vol.52, no.2, 2020, ss.171 - 175. 10.5152/eurasianjmed.2020.18443
AMA KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E Is Ebselen A Therapeutic Target in Fracture Healing?. Eurasian Journal of Medicine. 2020; 52(2): 171 - 175. 10.5152/eurasianjmed.2020.18443
Vancouver KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E Is Ebselen A Therapeutic Target in Fracture Healing?. Eurasian Journal of Medicine. 2020; 52(2): 171 - 175. 10.5152/eurasianjmed.2020.18443
IEEE KÖSE A,KOSE D,Halici Z,Aydın A,Ezirmik N,KARSAN O,TOKTAY E "Is Ebselen A Therapeutic Target in Fracture Healing?." Eurasian Journal of Medicine, 52, ss.171 - 175, 2020. 10.5152/eurasianjmed.2020.18443
ISNAD KÖSE, AHMET vd. "Is Ebselen A Therapeutic Target in Fracture Healing?". Eurasian Journal of Medicine 52/2 (2020), 171-175. https://doi.org/10.5152/eurasianjmed.2020.18443